KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Cost of Revenue: 2017-2025

Historic Cost of Revenue for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to $530.0 million.

  • Elanco Animal Health's Cost of Revenue rose 7.72% to $530.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 2.48%. This contributed to the annual value of $2.0 billion for FY2024, which is 3.73% up from last year.
  • Per Elanco Animal Health's latest filing, its Cost of Revenue stood at $530.0 million for Q3 2025, which was up 0.38% from $528.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Cost of Revenue ranged from a high of $566.0 million in Q1 2021 and a low of $434.0 million during Q2 2023.
  • Over the past 3 years, Elanco Animal Health's median Cost of Revenue value was $501.0 million (recorded in 2024), while the average stood at $500.1 million.
  • Within the past 5 years, the most significant YoY rise in Elanco Animal Health's Cost of Revenue was 86.15% (2021), while the steepest drop was 14.46% (2021).
  • Quarterly analysis of 5 years shows Elanco Animal Health's Cost of Revenue stood at $510.0 million in 2021, then fell by 12.16% to $448.0 million in 2022, then increased by 15.18% to $516.0 million in 2023, then fell by 2.91% to $501.0 million in 2024, then increased by 7.72% to $530.0 million in 2025.
  • Its Cost of Revenue stands at $530.0 million for Q3 2025, versus $528.0 million for Q2 2025 and $509.0 million for Q1 2025.